CA Stock MarketDetailed Quotes

Biomark Diagnostics Inc (BUX)

Watchlist
  • 0.590
  • +0.010+1.72%
15min DelayMarket Closed May 1 14:23 ET
62.00MMarket Cap-29.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomark Diagnostics Inc (BUX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.16%-201.55K
-268.83%-481.83K
10.90%-285.73K
-11.26%-1.09M
-110.73%-451.95K
62.51%-189.85K
-1,002.24%-130.64K
-28.39%-320.69K
-7.45%-982.52K
-22.39%-214.47K
Net income from continuing operations
-13.61%-380.32K
12.04%-481.39K
33.25%-416.01K
-35.02%-1.93M
-7.83%-421.93K
17.70%-334.77K
-160.05%-547.3K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
Depreciation and amortization
141.08%141.02K
48.71%86.5K
73.93%100.45K
2.06%401.27K
124.95%226.86K
-40.94%58.49K
-35.74%58.17K
-43.80%57.76K
1.81%393.17K
-1.84%100.85K
Remuneration paid in stock
57.41%24.89K
-87.65%13.77K
-97.07%6.14K
385.75%366.65K
450.64%29.91K
0.11%15.81K
243.73%111.54K
485.43%209.39K
-77.09%75.48K
-239.77%-8.53K
Other non cashItems
-27.13%10.31K
-61.44%6.39K
-52.11%9.05K
-2.25%61.25K
-33.48%11.64K
-12.52%14.15K
22.20%16.56K
22.45%18.9K
-15.84%62.66K
-76.86%17.5K
Change In working capital
-95.47%2.56K
-146.48%-107.09K
-11.52%14.63K
105.76%4.98K
-545.28%-298.43K
124.48%56.47K
271.05%230.4K
9.46%16.54K
-162.81%-86.45K
-52.73%67.02K
-Change in receivables
-356.15%-15.28K
82.32%-6.45K
-177.42%-9.3K
-1,259.31%-117.64K
-2,128.67%-89.85K
80.54%-3.35K
-530.81%-36.45K
21.20%12.01K
-118.12%-8.65K
136.01%4.43K
-Change in prepaid assets
--0
---16.22K
--450
---450
---450
--0
--0
--0
--0
----
-Change in payables and accrued expense
-70.18%17.84K
-131.64%-84.43K
418.87%23.48K
258.19%123.07K
-443.62%-208.13K
128.29%59.82K
293.16%266.85K
-12.91%4.53K
-186.57%-77.8K
-59.83%60.57K
Cash from discontinued investing activities
Operating cash flow
-6.16%-201.55K
-268.83%-481.83K
10.90%-285.73K
-11.26%-1.09M
-110.73%-451.95K
62.51%-189.85K
-1,002.24%-130.64K
-28.39%-320.69K
-7.45%-982.52K
-22.39%-214.47K
Investing cash flow
Cash flow from continuing investing activities
-591.82K
1.05M
-75,036.80%-1.88M
19.59%-3.53K
17.07%-1.03K
0
0
-2.51K
17.08%-4.39K
-123,500.00%-1.24K
Net PPE purchase and sale
---617.42K
---8.72K
20.06%-2.01K
19.59%-3.53K
17.07%-1.03K
--0
--0
---2.51K
17.08%-4.39K
-123,500.00%-1.24K
Net investment purchase and sale
--25.59K
--1.06M
---1.88M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---591.82K
--1.05M
-75,036.80%-1.88M
19.59%-3.53K
17.07%-1.03K
--0
--0
---2.51K
17.08%-4.39K
-123,500.00%-1.24K
Financing cash flow
Cash flow from continuing financing activities
129.52%559.53K
-343.07%-58.15K
-132.39%-99.71K
219.30%3.42M
4,689.97%2.85M
-62.68%243.79K
297.61%23.92K
-12.79%307.81K
75.95%1.07M
-47.59%59.42K
Net issuance payments of debt
603.81%520.22K
64.57%-36.45K
-1.11%-104.02K
43.62%-413.03K
64.76%-104.02K
-2.15%-103.26K
56.18%-102.88K
-1.20%-102.88K
-144.23%-732.64K
-84.38%-295.13K
Net common stock issuance
----
----
----
134.21%3.61M
--3.61M
----
----
----
155.62%1.54M
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
--0
--0
Net other financing activities
-88.67%39.3K
-117.11%-21.7K
-98.95%4.3K
-14.82%223.51K
-286.44%-661.02K
144.06%347.04K
-47.34%126.8K
-9.67%410.69K
-2.21%262.4K
29.67%354.55K
Cash from discontinued financing activities
Financing cash flow
129.52%559.53K
-343.07%-58.15K
-132.39%-99.71K
219.30%3.42M
4,689.97%2.85M
-62.68%243.79K
297.61%23.92K
-12.79%307.81K
75.95%1.07M
-47.59%59.42K
Net cash flow
Beginning cash position
1,982.67%721.54K
49.90%211.89K
1,483.27%2.48M
117.60%156.75K
-71.70%88.58K
-79.43%34.65K
-19.33%141.36K
117.60%156.75K
-81.18%72.04K
133.78%313.03K
Current changes in cash
-533.54%-233.84K
577.59%509.65K
-14,648.05%-2.27M
2,644.61%2.33M
1,631.31%2.39M
-62.70%53.94K
-1,471.16%-106.71K
-114.91%-15.39K
127.27%84.71K
-152.63%-156.28K
End cash Position
450.56%487.7K
1,982.67%721.54K
49.90%211.89K
1,483.27%2.48M
1,483.27%2.48M
-71.70%88.58K
-79.43%34.65K
-19.33%141.36K
117.60%156.75K
117.60%156.75K
Free cash from
-331.38%-818.96K
-275.50%-490.55K
10.97%-287.74K
-11.12%-1.1M
-110.00%-452.97K
62.67%-189.85K
-919.88%-130.64K
-29.40%-323.2K
-7.31%-986.92K
-23.10%-215.7K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.16%-201.55K-268.83%-481.83K10.90%-285.73K-11.26%-1.09M-110.73%-451.95K62.51%-189.85K-1,002.24%-130.64K-28.39%-320.69K-7.45%-982.52K-22.39%-214.47K
Net income from continuing operations -13.61%-380.32K12.04%-481.39K33.25%-416.01K-35.02%-1.93M-7.83%-421.93K17.70%-334.77K-160.05%-547.3K-48.80%-623.28K22.52%-1.43M21.97%-391.31K
Depreciation and amortization 141.08%141.02K48.71%86.5K73.93%100.45K2.06%401.27K124.95%226.86K-40.94%58.49K-35.74%58.17K-43.80%57.76K1.81%393.17K-1.84%100.85K
Remuneration paid in stock 57.41%24.89K-87.65%13.77K-97.07%6.14K385.75%366.65K450.64%29.91K0.11%15.81K243.73%111.54K485.43%209.39K-77.09%75.48K-239.77%-8.53K
Other non cashItems -27.13%10.31K-61.44%6.39K-52.11%9.05K-2.25%61.25K-33.48%11.64K-12.52%14.15K22.20%16.56K22.45%18.9K-15.84%62.66K-76.86%17.5K
Change In working capital -95.47%2.56K-146.48%-107.09K-11.52%14.63K105.76%4.98K-545.28%-298.43K124.48%56.47K271.05%230.4K9.46%16.54K-162.81%-86.45K-52.73%67.02K
-Change in receivables -356.15%-15.28K82.32%-6.45K-177.42%-9.3K-1,259.31%-117.64K-2,128.67%-89.85K80.54%-3.35K-530.81%-36.45K21.20%12.01K-118.12%-8.65K136.01%4.43K
-Change in prepaid assets --0---16.22K--450---450---450--0--0--0--0----
-Change in payables and accrued expense -70.18%17.84K-131.64%-84.43K418.87%23.48K258.19%123.07K-443.62%-208.13K128.29%59.82K293.16%266.85K-12.91%4.53K-186.57%-77.8K-59.83%60.57K
Cash from discontinued investing activities
Operating cash flow -6.16%-201.55K-268.83%-481.83K10.90%-285.73K-11.26%-1.09M-110.73%-451.95K62.51%-189.85K-1,002.24%-130.64K-28.39%-320.69K-7.45%-982.52K-22.39%-214.47K
Investing cash flow
Cash flow from continuing investing activities -591.82K1.05M-75,036.80%-1.88M19.59%-3.53K17.07%-1.03K00-2.51K17.08%-4.39K-123,500.00%-1.24K
Net PPE purchase and sale ---617.42K---8.72K20.06%-2.01K19.59%-3.53K17.07%-1.03K--0--0---2.51K17.08%-4.39K-123,500.00%-1.24K
Net investment purchase and sale --25.59K--1.06M---1.88M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---591.82K--1.05M-75,036.80%-1.88M19.59%-3.53K17.07%-1.03K--0--0---2.51K17.08%-4.39K-123,500.00%-1.24K
Financing cash flow
Cash flow from continuing financing activities 129.52%559.53K-343.07%-58.15K-132.39%-99.71K219.30%3.42M4,689.97%2.85M-62.68%243.79K297.61%23.92K-12.79%307.81K75.95%1.07M-47.59%59.42K
Net issuance payments of debt 603.81%520.22K64.57%-36.45K-1.11%-104.02K43.62%-413.03K64.76%-104.02K-2.15%-103.26K56.18%-102.88K-1.20%-102.88K-144.23%-732.64K-84.38%-295.13K
Net common stock issuance ------------134.21%3.61M--3.61M------------155.62%1.54M--0
Proceeds from stock option exercised by employees ----------------------------------0--0
Net other financing activities -88.67%39.3K-117.11%-21.7K-98.95%4.3K-14.82%223.51K-286.44%-661.02K144.06%347.04K-47.34%126.8K-9.67%410.69K-2.21%262.4K29.67%354.55K
Cash from discontinued financing activities
Financing cash flow 129.52%559.53K-343.07%-58.15K-132.39%-99.71K219.30%3.42M4,689.97%2.85M-62.68%243.79K297.61%23.92K-12.79%307.81K75.95%1.07M-47.59%59.42K
Net cash flow
Beginning cash position 1,982.67%721.54K49.90%211.89K1,483.27%2.48M117.60%156.75K-71.70%88.58K-79.43%34.65K-19.33%141.36K117.60%156.75K-81.18%72.04K133.78%313.03K
Current changes in cash -533.54%-233.84K577.59%509.65K-14,648.05%-2.27M2,644.61%2.33M1,631.31%2.39M-62.70%53.94K-1,471.16%-106.71K-114.91%-15.39K127.27%84.71K-152.63%-156.28K
End cash Position 450.56%487.7K1,982.67%721.54K49.90%211.89K1,483.27%2.48M1,483.27%2.48M-71.70%88.58K-79.43%34.65K-19.33%141.36K117.60%156.75K117.60%156.75K
Free cash from -331.38%-818.96K-275.50%-490.55K10.97%-287.74K-11.12%-1.1M-110.00%-452.97K62.67%-189.85K-919.88%-130.64K-29.40%-323.2K-7.31%-986.92K-23.10%-215.7K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -